查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1547061

乾眼症治療設備市場：2024-2031年全球產業分析、規模、佔有率、成長、趨勢、預測

Dry Eye Disease Treatment Devices Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 160 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research最近發布了一份關於全球乾眼症（DED）治療設備市場的綜合報告。本報告對關鍵市場動態進行了深入分析，包括驅動因素、趨勢、機會和挑戰，並對市場結構提供了深入的見解。

關鍵見解

  • 乾眼症治療設備市場規模（2024年）：2.123億美元
  • 預測市場規模（2031年）：3.451億美元
  • 全球市場成長率（2024-2031年年複合成長率）：6.2%

乾眼症治療設備市場 - 研究範圍：

乾眼症治療設備對於控制乾眼症的症狀非常重要，乾眼症的特徵是淚液分泌不足和淚液品質差。這些設備包括多種技術，例如穿刺塞、熱脈動系統和強烈脈衝光（IPL）設備，目的是緩解症狀、改善淚液生成並提高患者舒適度。市場為各種環境中不同嚴重程度和類型的乾眼症提供解決方案，包括眼科診所、醫院和家庭護理環境。

推動市場成長的因素：

全球乾眼症治療設備市場由幾個關鍵因素推動。由於螢幕時間增加、環境因素和人口老化，乾眼症的盛行率不斷上升，是主要的成長動力。治療技術的進步，包括改進的穿刺塞設計以及先進的熱脈動和 IPL 設備的開發，有助於提高治療效果和患者滿意度。此外，人們對乾眼症的認識不斷提高，以及更先進、對患者友善的治療方案的出現，也推動了市場的擴張。

市場限制因素：

儘管乾眼症治療設備市場成長前景廣闊，但仍面臨挑戰。高昂的治療費用和有限的保險範圍可能會限制患者的治療和採用率，尤其是在醫療保健預算有限的新興國家。監管障礙和新技術臨床驗證的需求也可能影響市場成長。解決這些問題需要製造商、醫療保健提供者和政策制定者共同努力，以提高乾眼治療解決方案的可用性和可負擔性。

市場機會：

由於技術進步和不斷發展的醫療保健實踐，乾眼症治療設備市場提供了龐大的商機。數位醫療技術的集成，例如用於症狀追蹤和遠距醫療諮詢的行動應用程序，可以增強患者的參與度和對治療方案的遵守。此外，將治療設備的使用擴展到傳統應用之外，例如治療乾眼症和相關疾病的嚴重病例，為市場成長開闢了新的途徑。策略合作夥伴關係、持續的研發以及設備設計和功能的創新對於利用這些機會並保持市場競爭力非常重要。

本報告解決的關鍵問題

  • 推動全球乾眼治療設備市場成長的關鍵因素是什麼？
  • 各種醫療機構採用哪些類型的設備和治療方法？
  • 技術進步如何改變乾眼症治療設備市場的競爭格局？
  • 誰是乾眼症治療設備市場的主要參與者？
  • 全球乾眼症治療器材市場的新趨勢與未來前景如何？

目錄

第1章 執行摘要

第2章 市場概述

  • 市場範圍與定義
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會
    • 課題
    • 主要趨勢
  • 宏觀經濟因素
    • 全球 GDP 成長前景
    • 全球醫療保健產業概覽
  • 預測因子 - 相關性和影響

第3章 增值見解

  • 產品類型生命週期分析
  • 疾病流行病學
  • 乾眼症治療設備市場：價值鏈
  • 母市場分析
  • 新冠肺炎（COVID-19）影響評估
  • PESTLE分析
  • 波特五力分析
  • 監管與科技環境

第4章 全球乾眼症治療設備市場展望：實績（2019-2023年）與預測（2024-2031年）

  • 主要亮點
    • 市場數量（單位）預測
    • 市場規模及年成長率
    • 絕對數量的機會
  • 市場規模（百萬美元）分析與預測
    • 過去的市場規模分析，2019-2023年
    • 目前市場規模預測（2023-2031年）
  • 全球乾眼症治療設備市場展望：產品類型
    • 簡介/主要發現
    • 2019-2023年歷史市場規模（百萬美元）和數量（單位）分析，依產品類型
    • 2024-2031年當前市場規模（百萬美元）和數量（單位）預測，依產品類型
  • 市場吸引力分析：產品類型
  • 全球乾眼症治療設備市場展望：原因
    • 簡介/主要發現
    • 2019-2023年歷史市場規模（百萬美元）分析：依原因
    • 2024-2031年當前市場規模（百萬美元）預測：依原因
  • 市場吸引力分析：原因
  • 全球乾眼症治療設備市場前景：應用
    • 簡介/主要發現
    • 2019-2023年歷史市場規模（百萬美元）分析：依應用
    • 2024-2031年當前市場規模（百萬美元）預測：依應用
  • 市場吸引力分析：應用
  • 全球乾眼症治療設備市場展望：最終用途
    • 簡介/主要發現
    • 2019-2023年歷史市場規模（百萬美元）分析：依最終用途
    • 2024-2031年當前市場規模（百萬美元）預測：依最終用途
  • 市場吸引力分析：最終用途

第5章 全球乾眼症治療設備市場展望：地區

  • 主要亮點
  • 2019-2023年過往市場規模（百萬美元）和數量（單位）分析，依地區
  • 2024-2031年當前市場規模（百萬美元）和數量（單位）預測，依地區
    • 北美
    • 歐洲
    • 東亞
    • 南亞/大洋洲
    • 拉丁美洲
    • 中東、非洲
  • 市場吸引力分析：地區

第6章 北美乾眼症治療設備市場展望：實績（2019-2023）與預測（2024-2031）

第7章 歐洲乾眼症治療設備市場展望：實績（2019-2023年）與預測（2024-2031年）

第8章 東亞乾眼症治療設備市場展望：實績（2019-2023年）與預測（2024-2031年）

第9章 南亞/大洋洲乾眼症治療設備市場展望：實績（2019-2023）與預測（2024-2031）

第10章 拉丁美洲乾眼症治療設備市場展望：實績（2019-2023年）與預測（2024-2031年）

第11章 中東與非洲乾眼症治療設備市場展望：實績（2019-2023年）與預測（2024-2031年）

第12章 競爭態勢

  • 2023年市佔率分析
  • 市場結構
    • 競爭強度圖：依市場劃分
    • 競爭儀表板
    • 表觀產能
  • 公司簡介（詳細資料 - 概述、財務狀況、策略、近期發展）
    • Johnson and Johnson Services Inc.
    • AbbVie Inc.
    • Lumenis Be Ltd
    • ESW-Vision
    • Mibo Medical Group
    • Sight Sciences.
    • Eyedetect Medical Inc.
    • BlephEx
    • NuSight Medicals-Nulids LLC
    • 其他

第13章 附錄

  • 調查方法
  • 調查的先決條件
  • 首字母縮寫詞和縮寫詞
簡介目錄
Product Code: PMRREP34725

Persistence Market Research has recently released a comprehensive report on the global market for dry eye disease (DED) treatment devices. This report provides an in-depth analysis of crucial market dynamics, including drivers, trends, opportunities, and challenges, offering detailed insights into the market structure.

Key Insights:

  • Dry Eye Disease Treatment Devices Market Size (2024E): US$212.3 Mn
  • Projected Market Value (2031F): US$345.1 Mn
  • Global Market Growth Rate (CAGR 2024 to 2031): 6.2%

Dry Eye Disease Treatment Devices Market - Report Scope:

Dry eye disease treatment devices are integral to managing symptoms of dry eye disease, a condition characterized by inadequate tear production or poor tear quality. These devices include a range of technologies such as punctal plugs, thermal pulsation systems, and intense pulsed light (IPL) devices, which aim to alleviate symptoms, improve tear production, and enhance patient comfort. The market serves various settings including ophthalmology clinics, hospitals, and homecare environments, offering solutions that cater to different severities and types of dry eye disease.

Market Growth Drivers:

The global dry eye disease treatment devices market is driven by several key factors. Increasing prevalence of dry eye disease, spurred by rising screen time, environmental factors, and aging populations, is a significant growth driver. Advances in treatment technology, including improved punctal plug designs and the development of sophisticated thermal pulsation and IPL devices, contribute to enhanced treatment efficacy and patient satisfaction. Additionally, growing awareness about dry eye disease and the availability of more advanced and patient-friendly treatment options further fuel market expansion.

Market Restraints:

Despite promising growth prospects, the dry eye disease treatment devices market faces challenges. High treatment costs and limited insurance coverage can restrict patient access and adoption rates, particularly in emerging economies with constrained healthcare budgets. Regulatory hurdles and the need for clinical validation of new technologies can also impact market growth. Addressing these issues requires collaboration between manufacturers, healthcare providers, and policymakers to improve accessibility and affordability of dry eye disease treatment solutions.

Market Opportunities:

The dry eye disease treatment devices market presents significant opportunities driven by technological advancements and evolving healthcare practices. The integration of digital health technologies, such as mobile apps for symptom tracking and telemedicine consultations, enhances patient engagement and adherence to treatment protocols. Moreover, expanding applications of treatment devices beyond traditional uses, such as for managing severe cases of dry eye disease and associated conditions, open new avenues for market growth. Strategic partnerships, ongoing R&D, and innovation in device design and functionality are crucial to capitalizing on these opportunities and maintaining a competitive edge in the market.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the dry eye disease treatment devices market globally?
  • Which types of devices and treatment methods are leading adoption across different healthcare settings?
  • How are technological advancements reshaping the competitive landscape of the dry eye disease treatment devices market?
  • Who are the key players contributing to the dry eye disease treatment devices market, and what strategies are they employing to stay relevant?
  • What are the emerging trends and future prospects in the global dry eye disease treatment devices market?

Competitive Intelligence and Business Strategy:

Leading players in the global dry eye disease treatment devices market, including Allergan plc, Johnson & Johnson Vision, and TearLab Corporation, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced treatment devices, such as next-generation thermal pulsation systems and enhanced punctal plugs. Collaborations with healthcare providers and investment in marketing and education programs foster market growth and improve patient outcomes. Additionally, emphasis on clinical research and evidence-based practices supports market expansion and drives innovation in the dry eye disease treatment landscape.

Key Companies Profiled:

  • Allergan plc
  • Johnson & Johnson Vision
  • TearLab Corporation
  • Alcon Laboratories, Inc.
  • Ocular Therapeutix, Inc.
  • EyeGate Pharmaceuticals, Inc.
  • Shire Pharmaceuticals
  • Novartis AG
  • Bausch & Lomb Incorporated
  • Ciba Vision Corporation

Dry Eye Disease Treatment Devices Market Segmentation

By Product Type

  • Meibomian Gland Unclogging Devices
  • Wearable Devices
  • Punctual Occlusion Devices
  • Pain Relieving Devices

By Cause

  • Idiopathic
  • Rare Disease
  • Surgery
  • Drug Intake Associated
  • Digital Exposure
  • Age-Related

By Application

  • Chronic Dry Eye
  • Acute Dry Eye

By End User

  • Hospitals and Clinics
  • Home Care

By Region

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Dry Eye Disease Treatment Devices Market Snapshot, 2024-2031
  • 1.2. Market Opportunity Assessment, 2024-2031, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global GDP Growth Outlook
    • 2.3.2. Global Healthcare Industry Overview
  • 2.4. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product Type Lifecycle Analysis
  • 3.2. Disease Epidemiology
  • 3.3. Dry Eye Disease Treatment Devices Market: Value Chain
  • 3.4. Parent Market Analysis
  • 3.5. Covid-19 Impact Assessment
  • 3.6. PESTLE Analysis
  • 3.7. Porter Five Force's Analysis
  • 3.8. Regulatory and Technology Landscape

4. Global Dry Eye Disease Treatment Devices Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 4.1. Key Highlights
    • 4.1.1. Market Volume (Units) Projections
    • 4.1.2. Market Size and Y-o-Y Growth
    • 4.1.3. Absolute $ Opportunity
  • 4.2. Market Size (US$ Mn) Analysis and Forecast
    • 4.2.1. Historical Market Size Analysis, 2019-2023
    • 4.2.2. Current Market Size Forecast, 2023-2031
  • 4.3. Global Dry Eye Disease Treatment Devices Market Outlook: Product Type
    • 4.3.1. Introduction / Key Findings
    • 4.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product Type, 2019-2023
    • 4.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2024-2031
      • 4.3.3.1. Meibomian Gland Unclogging Devices
      • 4.3.3.2. Wearable Devices
      • 4.3.3.3. Punctual Occlusion Devices
      • 4.3.3.4. Pain Relieving Devices
      • 4.3.3.5. Others
  • 4.4. Market Attractiveness Analysis: Product Type
  • 4.5. Global Dry Eye Disease Treatment Devices Market Outlook: Cause
    • 4.5.1. Introduction / Key Findings
    • 4.5.2. Historical Market Size (US$ Mn) Analysis By Cause, 2019-2023
    • 4.5.3. Current Market Size (US$ Mn Forecast By Cause, 2024-2031
      • 4.5.3.1. Idiopathic
      • 4.5.3.2. Rare Disease
      • 4.5.3.3. Surgery
      • 4.5.3.4. Drug Intake Associated
      • 4.5.3.5. Digital Exposure
      • 4.5.3.6. Age-Related
  • 4.6. Market Attractiveness Analysis: Cause
  • 4.7. Global Dry Eye Disease Treatment Devices Market Outlook: Application
    • 4.7.1. Introduction / Key Findings
    • 4.7.2. Historical Market Size (US$ Mn) Analysis By Application, 2019-2023
    • 4.7.3. Current Market Size (US$ Mn Forecast By Application, 2024-2031
      • 4.7.3.1. Chronic Dry Eye
      • 4.7.3.2. Acute Dry Eye
  • 4.8. Market Attractiveness Analysis: Application
  • 4.9. Global Dry Eye Disease Treatment Devices Market Outlook: End Use
    • 4.9.1. Introduction / Key Findings
    • 4.9.2. Historical Market Size (US$ Mn) Analysis By End Use, 2019-2023
    • 4.9.3. Current Market Size (US$ Mn) Forecast By End Use, 2024-2031
      • 4.9.3.1. Hospitals and Clinics
      • 4.9.3.2. Home Care
  • 4.10. Market Attractiveness Analysis: End Use

5. Global Dry Eye Disease Treatment Devices Market Outlook: Region

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2019-2023
  • 5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2024-2031
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. East Asia
    • 5.3.4. South Asia and Oceania
    • 5.3.5. Latin America
    • 5.3.6. Middle East & Africa
  • 5.4. Market Attractiveness Analysis: Region

6. North America Dry Eye Disease Treatment Devices Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 6.1. Key Highlights
  • 6.2. Pricing Analysis
  • 6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019-2023
    • 6.3.1. By Country
    • 6.3.2. By Product Type
    • 6.3.3. By Cause
    • 6.3.4. By Application
    • 6.3.5. By End Use
  • 6.4. Current Market Size (US$ Mn) Forecast By Country, 2024-2031
    • 6.4.1. U.S.
    • 6.4.2. Canada
  • 6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2024-2031
    • 6.5.1. Meibomian Gland Unclogging Devices
    • 6.5.2. Wearable Devices
    • 6.5.3. Punctual Occlusion Devices
    • 6.5.4. Pain Relieving Devices
    • 6.5.5. Others
  • 6.6. Current Market Size (US$ Mn) Forecast By Cause, 2024-2031
    • 6.6.1. Idiopathic
    • 6.6.2. Rare Disease
    • 6.6.3. Surgery
    • 6.6.4. Drug Intake Associated
    • 6.6.5. Digital Exposure
    • 6.6.6. Age-Related
  • 6.7. Current Market Size (US$ Mn) Forecast By Application, 2024-2031
    • 6.7.1. Chronic Dry Eye
    • 6.7.2. Acute Dry Eye
  • 6.8. Market Attractiveness Analysis
  • 6.9. Current Market Size (US$ Mn) Forecast By End Use, 2024-2031
    • 6.9.1. Hospitals and Clinics
    • 6.9.2. Home Care
  • 6.10. Market Attractiveness Analysis

7. Europe Dry Eye Disease Treatment Devices Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 7.1. Key Highlights
  • 7.2. Pricing Analysis
  • 7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019-2023
    • 7.3.1. By Country
    • 7.3.2. By Product Type
    • 7.3.3. By Cause
    • 7.3.4. By Application
    • 7.3.5. By End Use
  • 7.4. Current Market Size (US$ Mn) Forecast By Country, 2024-2031
    • 7.4.1. Germany
    • 7.4.2. France
    • 7.4.3. U.K.
    • 7.4.4. Italy
    • 7.4.5. Spain
    • 7.4.6. Russia
    • 7.4.7. Turkey
    • 7.4.8. Rest of Europe
  • 7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2024-2031
    • 7.5.1. Meibomian Gland Unclogging Devices
    • 7.5.2. Wearable Devices
    • 7.5.3. Punctual Occlusion Devices
    • 7.5.4. Pain Relieving Devices
    • 7.5.5. Others
  • 7.6. Current Market Size (US$ Mn) Forecast By Cause, 2024-2031
    • 7.6.1. Idiopathic
    • 7.6.2. Rare Disease
    • 7.6.3. Surgery
    • 7.6.4. Drug Intake Associated
    • 7.6.5. Digital Exposure
    • 7.6.6. Age-Related
  • 7.7. Current Market Size (US$ Mn) Forecast By Application, 2024-2031
    • 7.7.1. Chronic Dry Eye
    • 7.7.2. Acute Dry Eye
  • 7.8. Market Attractiveness Analysis
  • 7.9. Current Market Size (US$ Mn) Forecast By End Use, 2024-2031
    • 7.9.1. Hospitals and Clinics
    • 7.9.2. Home Care
  • 7.10. Market Attractiveness Analysis

8. East Asia Dry Eye Disease Treatment Devices Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 8.1. Key Highlights
  • 8.2. Pricing Analysis
  • 8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019-2023
    • 8.3.1. By Country
    • 8.3.2. By Product Type
    • 8.3.3. By Cause
    • 8.3.4. By Application
    • 8.3.5. By End Use
  • 8.4. Current Market Size (US$ Mn) Forecast By Country, 2024-2031
    • 8.4.1. China
    • 8.4.2. Japan
    • 8.4.3. South Korea
  • 8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2024-2031
    • 8.5.1. Meibomian Gland Unclogging Devices
    • 8.5.2. Wearable Devices
    • 8.5.3. Punctual Occlusion Devices
    • 8.5.4. Pain Relieving Devices
    • 8.5.5. Others
  • 8.6. Current Market Size (US$ Mn) Forecast By Cause, 2024-2031
    • 8.6.1. Idiopathic
    • 8.6.2. Rare Disease
    • 8.6.3. Surgery
    • 8.6.4. Drug Intake Associated
    • 8.6.5. Digital Exposure
    • 8.6.6. Age-Related
  • 8.7. Current Market Size (US$ Mn) Forecast By Application, 2024-2031
    • 8.7.1. Chronic Dry Eye
    • 8.7.2. Acute Dry Eye
  • 8.8. Market Attractiveness Analysis
  • 8.9. Current Market Size (US$ Mn) Forecast By End Use, 2024-2031
    • 8.9.1. Hospitals and Clinics
    • 8.9.2. Home Care
  • 8.10. Market Attractiveness Analysis

9. South Asia & Oceania Dry Eye Disease Treatment Devices Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 9.1. Key Highlights
  • 9.2. Pricing Analysis
  • 9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019-2023
    • 9.3.1. By Country
    • 9.3.2. By Product Type
    • 9.3.3. By Cause
    • 9.3.4. By Application
    • 9.3.5. By End Use
  • 9.4. Current Market Size (US$ Mn) Forecast By Country, 2024-2031
    • 9.4.1. India
    • 9.4.2. Southeast Asia
    • 9.4.3. ANZ
    • 9.4.4. Rest of South Asia & Oceania
  • 9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2024-2031
    • 9.5.1. Meibomian Gland Unclogging Devices
    • 9.5.2. Wearable Devices
    • 9.5.3. Punctual Occlusion Devices
    • 9.5.4. Pain Relieving Devices
    • 9.5.5. Others
  • 9.6. Current Market Size (US$ Mn) Forecast By Cause, 2024-2031
    • 9.6.1. Idiopathic
    • 9.6.2. Rare Disease
    • 9.6.3. Surgery
    • 9.6.4. Drug Intake Associated
    • 9.6.5. Digital Exposure
    • 9.6.6. Age-Related
  • 9.7. Current Market Size (US$ Mn) Forecast By Application, 2024-2031
    • 9.7.1. Chronic Dry Eye
    • 9.7.2. Acute Dry Eye
  • 9.8. Market Attractiveness Analysis
  • 9.9. Current Market Size (US$ Mn) Forecast By End Use, 2024-2031
    • 9.9.1. Hospitals and Clinics
    • 9.9.2. Home Care
  • 9.10. Market Attractiveness Analysis

10. Latin America Dry Eye Disease Treatment Devices Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 10.1. Key Highlights
  • 10.2. Pricing Analysis
  • 10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019-2023
    • 10.3.1. By Country
    • 10.3.2. By Product Type
    • 10.3.3. By Cause
    • 10.3.4. By Application
    • 10.3.5. By End Use
  • 10.4. Current Market Size (US$ Mn) Forecast By Country, 2024-2031
    • 10.4.1. Brazil
    • 10.4.2. Mexico
    • 10.4.3. Rest of Latin America
  • 10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2024-2031
    • 10.5.1. Meibomian Gland Unclogging Devices
    • 10.5.2. Wearable Devices
    • 10.5.3. Punctual Occlusion Devices
    • 10.5.4. Pain Relieving Devices
    • 10.5.5. Others
  • 10.6. Current Market Size (US$ Mn) Forecast By Cause, 2024-2031
    • 10.6.1. Idiopathic
    • 10.6.2. Rare Disease
    • 10.6.3. Surgery
    • 10.6.4. Drug Intake Associated
    • 10.6.5. Digital Exposure
    • 10.6.6. Age-Related
  • 10.7. Current Market Size (US$ Mn) Forecast By Application, 2024-2031
    • 10.7.1. Chronic Dry Eye
    • 10.7.2. Acute Dry Eye
  • 10.8. Market Attractiveness Analysis
  • 10.9. Current Market Size (US$ Mn) Forecast By End Use, 2024-2031
    • 10.9.1. Hospitals and Clinics
    • 10.9.2. Home Care
  • 10.10. Market Attractiveness Analysis

11. Middle East & Africa Dry Eye Disease Treatment Devices Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 11.1. Key Highlights
  • 11.2. Pricing Analysis
  • 11.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019-2023
    • 11.3.1. By Country
    • 11.3.2. By Product Type
    • 11.3.3. By Cause
    • 11.3.4. By Application
    • 11.3.5. By End Use
  • 11.4. Current Market Size (US$ Mn) Forecast By Country, 2024-2031
    • 11.4.1. GCC
    • 11.4.2. Egypt
    • 11.4.3. South Africa
    • 11.4.4. Northern Africa
    • 11.4.5. Rest of Middle East & Africa
  • 11.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2024-2031
    • 11.5.1. Meibomian Gland Unclogging Devices
    • 11.5.2. Wearable Devices
    • 11.5.3. Punctual Occlusion Devices
    • 11.5.4. Pain Relieving Devices
    • 11.5.5. Others
  • 11.6. Current Market Size (US$ Mn) Forecast By Cause, 2024-2031
    • 11.6.1. Idiopathic
    • 11.6.2. Rare Disease
    • 11.6.3. Surgery
    • 11.6.4. Drug Intake Associated
    • 11.6.5. Digital Exposure
    • 11.6.6. Age-Related
  • 11.7. Current Market Size (US$ Mn) Forecast By Application, 2024-2031
    • 11.7.1. Chronic Dry Eye
    • 11.7.2. Acute Dry Eye
  • 11.8. Market Attractiveness Analysis
  • 11.9. Current Market Size (US$ Mn) Forecast By End Use, 2024-2031
    • 11.9.1. Hospitals and Clinics
    • 11.9.2. Home Care
  • 11.10. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping By Market
    • 12.2.2. Competition Dashboard
    • 12.2.3. Apparent Production Capacity
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. Johnson and Johnson Services Inc.
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Products
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. AbbVie Inc.
    • 12.3.3. Lumenis Be Ltd
    • 12.3.4. ESW-Vision
    • 12.3.5. Mibo Medical Group
    • 12.3.6. Sight Sciences.
    • 12.3.7. Eyedetect Medical Inc.
    • 12.3.8. BlephEx
    • 12.3.9. NuSight Medicals-Nulids LLC
    • 12.3.10. Others

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations